- Home
- Publications
- Publication Search
- Publication Details
Title
Integrated genetic and pharmacologic interrogation of rare cancers
Authors
Keywords
-
Journal
Nature Communications
Volume 7, Issue -, Pages 11987
Publisher
Springer Nature
Online
2016-06-23
DOI
10.1038/ncomms11987
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rare cancers: a sea of opportunity
- (2016) Niki Boyd et al. LANCET ONCOLOGY
- Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells
- (2015) M. Rao et al. CLINICAL CANCER RESEARCH
- Rare Tumors in Children: Progress Through Collaboration
- (2015) Alberto S. Pappo et al. JOURNAL OF CLINICAL ONCOLOGY
- Correlating chemical sensitivity and basal gene expression reveals mechanism of action
- (2015) Matthew G Rees et al. Nature Chemical Biology
- High-throughput functional genomics using CRISPR–Cas9
- (2015) Ophir Shalem et al. NATURE REVIEWS GENETICS
- Pharmacodynamic and genomic markers associated with response to the XPO1/CRM1 inhibitor selinexor (KPT-330): A report from the pediatric preclinical testing program
- (2015) Edward F. Attiyeh et al. PEDIATRIC BLOOD & CANCER
- An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors
- (2015) Oliver Jonas et al. Science Translational Medicine
- Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours
- (2015) Tan A. Ince et al. Nature Communications
- Targeting CDK4 and CDK6: From Discovery to Therapy
- (2015) C. J. Sherr et al. Cancer Discovery
- Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset
- (2015) B. Seashore-Ludlow et al. Cancer Discovery
- Aging interventions get human
- (2015) Brian K. Kennedy et al. Oncotarget
- PRADA: pipeline for RNA sequencing data analysis
- (2014) Wandaliz Torres-García et al. BIOINFORMATICS
- Nucleo-cytoplasmic transport as a therapeutic target of cancer
- (2014) Giovanni Luca Gravina et al. Journal of Hematology & Oncology
- Discovery and saturation analysis of cancer genes across 21 tumour types
- (2014) Michael S. Lawrence et al. NATURE
- Rational design of highly active sgRNAs for CRISPR-Cas9–mediated gene inactivation
- (2014) John G Doench et al. NATURE BIOTECHNOLOGY
- Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine
- (2014) Eliezer M Van Allen et al. NATURE MEDICINE
- Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies
- (2014) Glenn S Cowley et al. Scientific Data
- Transcriptional and Epigenetic Dynamics during Specification of Human Embryonic Stem Cells
- (2013) Casey A. Gifford et al. CELL
- An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules
- (2013) Amrita Basu et al. CELL
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Evaluating cell lines as tumour models by comparison of genomic profiles
- (2013) Silvia Domcke et al. Nature Communications
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Raise standards for preclinical cancer research
- (2012) C. Glenn Begley et al. NATURE
- Use of Reprogrammed Cells to Identify Therapy for Respiratory Papillomatosis
- (2012) Hang Yuan et al. NEW ENGLAND JOURNAL OF MEDICINE
- C911: A Bench-Level Control for Sequence Specific siRNA Off-Target Effects
- (2012) Eugen Buehler et al. PLoS One
- Use and Abuse of RNAi to Study Mammalian Gene Function
- (2012) W. G. Kaelin SCIENCE
- ChimeraScan: a tool for identifying chimeric transcription in sequencing data
- (2011) Matthew K. Iyer et al. BIOINFORMATICS
- Rare cancers are not so rare: The rare cancer burden in Europe
- (2011) Gemma Gatta et al. EUROPEAN JOURNAL OF CANCER
- Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer
- (2011) H. W. Cheung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- "Creating Hope" and Other Incentives for Drug Development for Children
- (2011) E. Connor et al. Science Translational Medicine
- Anticancer drug development: the grand challenges
- (2010) William N. Hait NATURE REVIEWS DRUG DISCOVERY
- TheEML4-ALKfusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-typeEGFRandKRAS
- (2009) Daisy Wing-Sze Wong et al. CANCER
- Suppression of the Deubiquitinating Enzyme USP5 Causes the Accumulation of Unanchored Polyubiquitin and the Activation of p53
- (2008) Saurabh Dayal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Highly parallel identification of essential genes in cancer cells
- (2008) B. Luo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started